OSCR

Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma.

Overview

Authors: Purna Mukherjee1, Jack Maurer1, Sylwia A. Stopka2, Bennett Greenwood2, Juan J. Aristizabal-Henao2, Srada Karmacharya2, Alexandra Chimento1, Nathan Ta1, Derek C. Lee1, Tomas Duraj1, Roderick T. Bronson3, Michael A. Kiebish2, Thomas N. Seyfried1
  1. Department of Biology, Boston College, Chestnut Hill, MA 02467, USA
  2. BPGbio, Framingham, MA 01701, USA
  3. Rodent Pathology Core, Harvard Medical School, Boston, MA 02215, USA
Institutions: Boston College (United States); BPGbio, Inc. (United States) (United States); Harvard University (United States)
Journal: Cell reports. Medicine, volume 7, issue 6, article 102845
Dates: received 25 November 2025; accepted 11 May 2026; published online 16 June 2026; in print June 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.xcrm.2026.102845 · PMID 42302750 · PMCID PMC13293999 · OpenAlex W7164933035
Open access: gold, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: human (organism), mouse (organism), other condition (population), clinical / translational (subfield)
Methods: Statistics
Keywords: spinal cord, glutaminolysis, glycolysis, metabolic therapy, press-pulse, glutamine, childhood brain cancer, glucose, ketones
MeSH: Brain Neoplasms*, Diet, Ketogenic*, Glioma*, Mebendazole*, Animals, Cell Line, Tumor, Cell Proliferation, Female, Glycolysis, Humans, Mice (* major topic)
Topic: Diet and metabolism studies (Physiology (medical), Medicine), according to OpenAlex
Citations: cited by 2 papers (Europe PMC); 101 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Code and data availability statement

The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request
  • it says that the code is available on request

Read it in the paper: doi.org/10.1016/j.xcrm.2026.102845.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Thomas N. Seyfried (0000-0003-1491-3989); removed Thomas N. Seyfried

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 13 authors, 9 keywords, 11 MeSH terms, 4 funders, 101 references.

Cite

This paper

Mukherjee, P., Maurer, J., Stopka, S. A., Greenwood, B., Aristizabal-Henao, J. J., Karmacharya, S., Chimento, A., Ta, N., Lee, D. C., Duraj, T., Bronson, R. T., Kiebish, M. A., & Seyfried, T. N. (2026). Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma. Cell reports. Medicine, 7(6), 102845. https://doi.org/10.1016/j.xcrm.2026.102845

BibTeX

@article{mukherjee2026ketogenic,
author = {Mukherjee, Purna and Maurer, Jack and Stopka, Sylwia A. and Greenwood, Bennett and Aristizabal-Henao, Juan J. and Karmacharya, Srada and Chimento, Alexandra and Ta, Nathan and Lee, Derek C. and Duraj, Tomas and Bronson, Roderick T. and Kiebish, Michael A. and Seyfried, Thomas N.},
title = {{Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma}},
journal = {Cell reports. Medicine},
year = {2026},
month = jun,
volume = {7},
number = {6},
pages = {102845},
publisher = {Elsevier},
issn = {2666-3791},
doi = {10.1016/j.xcrm.2026.102845},
url = {https://doi.org/10.1016/j.xcrm.2026.102845},
pmid = {42302750},
pmcid = {PMC13293999}
}

RIS

TY - JOUR
AU - Mukherjee, Purna
AU - Maurer, Jack
AU - Stopka, Sylwia A.
AU - Greenwood, Bennett
AU - Aristizabal-Henao, Juan J.
AU - Karmacharya, Srada
AU - Chimento, Alexandra
AU - Ta, Nathan
AU - Lee, Derek C.
AU - Duraj, Tomas
AU - Bronson, Roderick T.
AU - Kiebish, Michael A.
AU - Seyfried, Thomas N.
TI - Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma
T2 - Cell reports. Medicine
J2 - Cell Rep Med
PY - 2026
DA - 2026/06/01
VL - 7
IS - 6
SP - 102845
SN - 2666-3791
PB - Elsevier
DO - 10.1016/j.xcrm.2026.102845
UR - https://doi.org/10.1016/j.xcrm.2026.102845
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.xcrm.2026.102845",
"type": "article-journal",
"title": "Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma",
"container-title": "Cell reports. Medicine",
"author": [
{
"family": "Mukherjee",
"given": "Purna"
},
{
"family": "Maurer",
"given": "Jack"
},
{
"family": "Stopka",
"given": "Sylwia A."
},
{
"family": "Greenwood",
"given": "Bennett"
},
{
"family": "Aristizabal-Henao",
"given": "Juan J."
},
{
"family": "Karmacharya",
"given": "Srada"
},
{
"family": "Chimento",
"given": "Alexandra"
},
{
"family": "Ta",
"given": "Nathan"
},
{
"family": "Lee",
"given": "Derek C."
},
{
"family": "Duraj",
"given": "Tomas"
},
{
"family": "Bronson",
"given": "Roderick T."
},
{
"family": "Kiebish",
"given": "Michael A."
},
{
"family": "Seyfried",
"given": "Thomas N."
}
],
"container-title-short": "Cell Rep Med",
"volume": "7",
"issue": "6",
"page": "102845",
"DOI": "10.1016/j.xcrm.2026.102845",
"PMID": "42302750",
"PMCID": "PMC13293999",
"ISSN": "2666-3791",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.xcrm.2026.102845",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12916-024-03775-4
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.
Journal: BMC medicine
In common: clinical / translational, other condition, 16 references
[2] doi:10.3390/ijms24043199
Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells.
Journal: International journal of molecular sciences
In common: other condition, 2 references
[3] doi:10.1158/1078-0432.ccr-22-0803 [code]
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
In common: other condition, 2 references
[4] doi:10.7554/elife.100570
Deuterium metabolic imaging phenotypes mouse glioblastoma heterogeneity through glucose turnover kinetics.
Journal: eLife
In common: other condition, mouse, 2 references
[5] doi:10.1016/j.bj.2025.100871
BrainView: A cloud-based deep learning system for brain image segmentation, tumor detection and visualization.
Journal: Biomedical journal
In common: other condition, 2 references
[6] doi:10.3390/microorganisms14061175
Susceptibility of the Placenta and Fetal Brain to Maternal Probiotic Supplementation.
Journal: Microorganisms
In common: 2 references
[7] doi:10.1172/jci177384
B cell-based therapy produces antibodies that inhibit glioblastoma growth.
Journal: The Journal of clinical investigation
In common: clinical / translational, other condition, mouse, 1 reference
[8] doi:10.1158/1078-0432.ccr-24-1256
The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
In common: clinical / translational, other condition, 1 reference
[9] doi:10.3390/ijms24032020
The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches.
Journal: International journal of molecular sciences
In common: clinical / translational, other condition, 1 reference
[10] doi:10.1038/s41598-025-26411-4 [code]
In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients.
Journal: Scientific reports
In common: clinical / translational, other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.